Showing results (1981-1990 of 2,138) with videos related to
Sort By:
Pageof 214
Blood Advances|December 21, 2018
Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)Gail J Roboz, Sumithra J Mandrekar, Pinkal Desai, et al.Haematologica|May 6, 2017
Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemiaDimitrios Papaioannou, Deedra Nicolet, Stefano Volinia, et al.Leukemia|December 12, 2013
GAS6 expression identifies high-risk adult AML patients: potential implications for therapySusan P Whitman, Jessica Kohlschmidt, Kati Maharry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemiaRichard M Stone, Emanuele Mazzola, Donna Neuberg, et al.Nature Cancer|December 29, 2022
An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemiaAudrey Lasry, Bettina Nadorp, Maarten Fornerod, et al.Nature Genetics|July 16, 2002
Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndromeKirk Mykytyn, Darryl Y Nishimura, Charles C Searby, et al.Blood|February 28, 2014
NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AMLSophia Adamia, Michal Bar-Natan, Benjamin Haibe-Kains, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 15, 2011
NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromesPeter L Greenberg, Eyal Attar, John M Bennett, et al.Oncotarget|July 23, 2016
Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignanciesXiaochuan Liu, Aoli Wang, Xiaofei Liang, et al.Ophthalmology|October 29, 2015
North Carolina Macular Dystrophy Is Caused by Dysregulation of the Retinal Transcription Factor PRDM13Kent W Small, Adam P DeLuca, S Scott Whitmore, et al.Pageof 214